David Sans
Corporate Officer/Principal bij CALIDI BIOTHERAPEUTICS, INC.
Vermogen: 10 347 $ op 31-03-2024
Profiel
David Sans is currently the Chief Corporate Development at Calidi Biotherapeutics, Inc. Prior to this, he worked as the Head of Business Development at ImClone LLC.
Mr. Sans holds a doctorate degree from Ramon Llull University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-09-2023 | 18 314 ( 0.05% ) | 10 347 $ | 31-03-2024 |
Actieve functies van David Sans
| Bedrijven | Functie | Begin |
|---|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
Eerdere bekende functies van David Sans
| Bedrijven | Functie | Einde |
|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Director/Board Member | - |
Opleiding van David Sans
| Ramon Llull University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
